Combination of the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus as a new option for epi-virotherapeutic treatment of hepatocellular carcinoma (HCC)

2015 ◽  
Vol 53 (08) ◽  
Author(s):  
B Ruf ◽  
S Berchtold ◽  
S Venturelli ◽  
I Smirnow ◽  
T Prenzel ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Vaccine Virus ◽  
Measles Vaccine ◽  
Deacetylase Inhibitor

scholarly journals Novel epi-virotherapeutic treatment of pancreatic cancer combining the oral histone deacetylase inhibitor resminostat with oncolytic measles vaccine virus

2016 ◽  
Vol 49 (5) ◽  
pp. 1931-1944 ◽  
Author(s):  
Tim Patrick Ellerhoff ◽  
Susanne Berchtold ◽  
Sascha Venturelli ◽  
Markus Burkard ◽  
Irina Smirnow ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Vaccine Virus ◽  
Measles Vaccine ◽  
Deacetylase Inhibitor

Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma

Hepatology ◽  
2007 ◽  
Vol 46 (4) ◽  
pp. 1119-1130 ◽  
Author(s):  
Yen-Shen Lu ◽  
Yoko Kashida ◽  
Samuel K. Kulp ◽  
Yu-Chieh Wang ◽  
Dasheng Wang ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Murine Models ◽  
Deacetylase Inhibitor
Sign in / Sign up

Export Citation Format

Share Document